Methotrexate vs Rituximab
Methotrexate vs Rituximab: Overview
This comparison examines the pharmacological differences between Methotrexate and Rituximab.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5.
Molecular Weight: Methotrexate — 454.4400 g/mol.
Type: Methotrexate — Small molecule; Rituximab — Antibody.